The MiDe Study’s Approach to Predict, Prevent and Detect Ovarian Cancer

episode

Cleveland Clinic Cancer Advances not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

A.I. Safety Goes Mainstream + a ‘Hard Fork’ Exit AMA 1h 25m · 18 Sep 2026 · Hard Fork

Layoffs at the Kansas City Star will hurt local communities 15 min · 18 Sep 2026 · Kansas City Today

The Lowe Job with Grace Alexander 1h 8m · 18 Sep 2026 · Barely Famous

3 Common Myths About Suicide - #526 13 min · 18 Sep 2026 · Something For Everybody

How OpenAI Built a Billion-Dollar Ad Engine 12 min · 18 Sep 2026 · WSJ Tech News Briefing

House of HorroR: Resident Evil 1h 24m · 18 Sep 2026 · House of R

Report any issue

Source

Recorded20 Mar 2025

Publisherfeeds.buzzsprout.com

Handlerec:1648147

Show notes

Kevin Elias, MD, the Lilli and Seth Harris Endowed Chair for Ovarian Cancer at Cleveland Clinic, joins the Cancer Advances podcast to discuss the challenges of trying to detect ovarian cancer early and the need for better predictive tools. Listen as Dr. Elias talks about the MiDe Study, which aims to identify high-risk women through microRNA-based blood tests, potentially transforming ovarian cancer screening and prevention.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in